About the Company
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Organon & Co. is an example of increasing women's representation on Wall Street with over 50% of its board of directors and executive leadership being female.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OGN News
Earnings Preview: Organon (OGN) Q1 Earnings Expected to Decline
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing
Organon (OGN) reachead $18.71 at the closing of the latest trading day, reflecting a +1.03% change compared to its last close.
Organon & Co. (OGN) Shares Up Despite Recent Market Volatility
In a nutshell, Organon & Co. (OGN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is ...
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Organon (OGN) closed at $18, marking a +1.01% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.87%. On the other hand, the ...
Organon’s Steady Market Position Maintains Neutral Rating Amidst Conservative Revenue Forecasts
Chris Shibutani, an analyst from Goldman Sachs, maintained the Hold rating on Organon (OGN – Research Report). The associated price ...
Stop the Misinformation, It's Time for Honesty: Organon Health Partner Dr. Kameelah Phillips Shares Why and How to Have Conversations With Your Kids About Sex and …
The birds and the bees. It's an important conversation for parents to have with their maturing children. But for even the ...
Organon & Co Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Organon (OGN) Advances While Market Declines: Some Information for Investors
In the latest trading session, Organon (OGN) closed at $17.71, marking a +1.49% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.2%. At the same time ...
Loading the latest forecasts...